Case processing backlog during inspection – regulatory enforcement risk and mitigation
In the investigation of a case processing backlog, identifying symptoms or signals is essential. These may manifest as:Click to read the full article.
Clinical & Pharmacovigilance
Periodic report inconsistencies during inspection – how to strengthen benefit–risk documentation
Identifying symptoms of periodic report inconsistencies is the first step in a thorough investigation. The following signs may indicate that further evaluation is required:Click to read the full article.
Risk management plan gaps during inspection – regulatory enforcement risk and mitigation
The first indicator that a gap may exist in a risk management plan occurs as signals manifest on the manufacturing floor or within laboratory operations. These may include:Click to read…
Case processing backlog during benefit–risk assessment – how to strengthen benefit–risk documentation
Identifying the symptoms associated with case processing backlog is critical to initiating an effective investigation. Symptoms may manifest through various signals, including:Click to read the full article.
Periodic report inconsistencies during audit response – regulatory enforcement risk and mitigation
The first critical step in addressing periodic report inconsistencies is recognizing the signals that indicate a problem. Symptoms may arise from various stages of the pharmaceutical manufacturing and quality control…
Periodic report inconsistencies during post-marketing surveillance – inspection questioning scenarios
The initial identification of anomalies in periodic reports often comes from various signals that staff may encounter during the monitoring process or by scrutinizing the reports themselves. Operators may notice…
AE reporting non-compliance during signal review – how to strengthen benefit–risk documentation
Identifying signals of AE reporting non-compliance during the signal review stage is crucial. Symptoms may manifest in various forms, including:Click to read the full article.
Literature surveillance failure during inspection – regulatory enforcement risk and mitigation
Identifying symptoms or signals of a literature surveillance failure is critical for timely and effective intervention. Symptoms may arise from various aspects of your pharmacovigilance activities and can include:Click to…
Literature surveillance failure during benefit–risk assessment – inspection questioning scenarios
Identifying symptoms of literature surveillance failures is the first step in initiating an investigation. Common signs include:Click to read the full article.
Case processing backlog during signal review – inspection questioning scenarios
Understanding the symptoms of a case processing backlog is the first step toward resolution. Symptoms may manifest as:Click to read the full article.
Case processing backlog during inspection – CAPA for PV system weaknesses
Identifying the telltale signs of a case processing backlog is the first step toward effective problem resolution. Symptoms may manifest in various forms, including:Click to read the full article.
Literature surveillance failure during audit response – how to strengthen benefit–risk documentation
In any pharmaceutical setting, awareness of signals is critical. Symptoms indicating a literature surveillance failure can manifest in various ways:Click to read the full article.